These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6251762)

  • 1. Captopril: an oral angiotension converting enzyme inhibitor active in man.
    Brunner HR; Gavras H; Waeber B; Turini GA; Wauters JP
    Arch Int Pharmacodyn Ther; 1980; Suppl():188-212. PubMed ID: 6251762
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of angiotensin converting enzyme inhibitor (SQ 14225) on renin-angiotesin sytem and haemodynamics (author's transl)].
    Shigetomi S
    Horumon To Rinsho; 1980; 28(5):531-5. PubMed ID: 6248275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of ACE-inhibition by captopril on renal formation and metabolism of angiotensins I and II in patients with renovascular hypertension.
    Hesse B; Rasmussen S; Giese J; Nielsen MD; Høilund-Carlsen PF
    Scand J Urol Nephrol Suppl; 1984; 79():45-8. PubMed ID: 6089318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 14. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
    Fagard R; Amery A; Lijnen P; Staessen J
    Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
    Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
    Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients.
    Wauters JP; Waeber B; Brunner HR; Turini GA; Guignard JP; Gavras H
    Proc Eur Dial Transplant Assoc; 1979; 16():610-7. PubMed ID: 232915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.